Serum AMH levels in healthy women from BRCA1/2 mutated families: are they reduced?

Theodora C. van Tilborg, Inge A. P. Derks-Smeets, Anna M. E. Bos, Jan C. Oosterwijk, Ron J. van Golde, Christine Smulders - de Die, Lizet E. van der Kolk, Wendy A. G. van Zelst-Stams, Maria E. Velthuizen, Annemieke Hoek, Marinus J. C. Eijkemans, Joop S. E. Laven, Margreet G. E. M. Ausems, Frank J. M. Broekmans

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)2651-2659
JournalHuman Reproduction
Volume31
Issue number11
DOIs
Publication statusPublished - Nov 2016

Keywords

  • anti-Mullerian hormone
  • BRCA mutation
  • ovarian reserve
  • ovarian aging
  • genes

Cite this

van Tilborg, T. C., Derks-Smeets, I. A. P., Bos, A. M. E., Oosterwijk, J. C., van Golde, R. J., Smulders - de Die, C., van der Kolk, L. E., van Zelst-Stams, W. A. G., Velthuizen, M. E., Hoek, A., Eijkemans, M. J. C., Laven, J. S. E., Ausems, M. G. E. M., & Broekmans, F. J. M. (2016). Serum AMH levels in healthy women from BRCA1/2 mutated families: are they reduced? Human Reproduction, 31(11), 2651-2659. https://doi.org/10.1093/humrep/dew242